ArticlePloS one2010

A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control.

Scott B Widenmaier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.